Sonnenschein Selected to Represent Specialty Pharmaceutical Company
September 11, 2009
Sonnenschein has been selected to represent Stymark, a development-stage specialty medical company, that is developing a series of products for the contraception market, using antimicrobial properties for the prevention of sexually transmitted diseases including AIDS. Sonnenschein will represent Stymark in general corporate and intellectual property matters.
